Suppr超能文献

我们对肠道微生物群与人类健康之间关联的认识的最新进展和尚存差距。

Recent advances and remaining gaps in our knowledge of associations between gut microbiota and human health.

作者信息

Mai Volker, Draganov Peter V

机构信息

Department of Gastroenterology, Hepatology and Nutrition, University of Florida, Gainesville, Florida 32610, USA.

出版信息

World J Gastroenterol. 2009 Jan 7;15(1):81-5. doi: 10.3748/wjg.15.81.

Abstract

The complex gut microbial flora harbored by individuals (microbiota) has long been proposed to contribute to intestinal health as well as disease. Pre- and probiotic products aimed at improving health by modifying microbiota composition have already become widely available and acceptance of these products appears to be on the rise. However, although required for the development of effective microbiota based interventions, our basic understanding of microbiota variation on a population level and its dynamics within individuals is still rudimentary. Powerful new parallel sequence technologies combined with other efficient molecular microbiota analysis methods now allow for comprehensive analysis of microbiota composition in large human populations. Recent findings in the field strongly suggest that microbiota contributes to the development of obesity, atopic diseases, inflammatory bowel diseases and intestinal cancers. Through the ongoing National Institutes of Health Roadmap 'Human Microbiome Project' and similar projects in other parts of the world, a large coordinated effort is currently underway to study how microbiota can impact human health. Translating findings from these studies into effective interventions that can improve health, possibly personalized based on an individuals existing microbiota, will be the task for the next decade(s).

摘要

长期以来,人们一直认为个体所携带的复杂肠道微生物群落(微生物群)对肠道健康以及疾病都有影响。旨在通过改变微生物群组成来改善健康的益生元和益生菌产品已广泛可得,而且这些产品的接受度似乎在上升。然而,尽管对于开发基于微生物群的有效干预措施来说这是必要的,但我们对人群水平上微生物群变异及其在个体内的动态变化的基本理解仍然很初步。强大的新型平行测序技术与其他高效的分子微生物群分析方法相结合,现在能够对大量人群的微生物群组成进行全面分析。该领域最近的研究结果强烈表明,微生物群与肥胖症、过敏性疾病、炎症性肠病和肠道癌症的发生有关。通过美国国立卫生研究院正在进行的“人类微生物组计划”以及世界其他地区的类似项目,目前正在开展一项大规模的协调研究工作,以探究微生物群如何影响人类健康。将这些研究结果转化为能够改善健康的有效干预措施,可能基于个体现有的微生物群进行个性化定制,这将是未来几十年的任务。

相似文献

3
[Intestinal microbiota: from antibiotic-associated diarrhea to inflammatory bowel diseases].
Presse Med. 2013 Jan;42(1):45-51. doi: 10.1016/j.lpm.2012.09.017. Epub 2012 Dec 20.
4
The gut microbiota in the metagenomics era: sometimes a friend, sometimes a foe.
Roum Arch Microbiol Immunol. 2011 Jul-Sep;70(3):134-40.
5
The human gut microbiome and body metabolism: implications for obesity and diabetes.
Clin Chem. 2013 Apr;59(4):617-28. doi: 10.1373/clinchem.2012.187617. Epub 2013 Feb 11.
6
Host responses to the human microbiome.
Nutr Rev. 2012 Aug;70 Suppl 1:S14-7. doi: 10.1111/j.1753-4887.2012.00496.x.
7
[The intestinal microbiota and inflammatory bowel disease].
Gastroenterol Hepatol. 2011 Mar;34(3):147-54. doi: 10.1016/j.gastrohep.2010.11.009. Epub 2011 Mar 5.
8
[The intestinal microbiota and human disease].
Korean J Gastroenterol. 2013 Aug 25;62(2):85-91. doi: 10.4166/kjg.2013.62.2.85.
9
Gut microbiota and probiotics in colon tumorigenesis.
Cancer Lett. 2011 Oct 28;309(2):119-27. doi: 10.1016/j.canlet.2011.06.004. Epub 2011 Jun 24.
10
Intestinal Microbiota in Inflammatory Bowel Disease and Carcinogenesis: Implication for Therapeutics.
Clin Pharmacol Ther. 2016 Jun;99(6):585-7. doi: 10.1002/cpt.348. Epub 2016 Feb 19.

引用本文的文献

2
Advancing prostate cancer treatment: the role of fecal microbiota transplantation as an adjuvant therapy.
Curr Res Microb Sci. 2025 Jun 11;9:100420. doi: 10.1016/j.crmicr.2025.100420. eCollection 2025.
3
Associations between diet and nutritional supplements and colorectal cancer: A systematic review.
JGH Open. 2024 Jul 18;8(7):e13108. doi: 10.1002/jgh3.13108. eCollection 2024 Jul.
4
Effect of Gut Microbiota on Blood Cholesterol: A Review on Mechanisms.
Foods. 2023 Nov 29;12(23):4308. doi: 10.3390/foods12234308.
7
Checkpoint inhibitor responses can be regulated by the gut microbiota - A systematic review.
Neoplasia. 2023 Sep;43:100923. doi: 10.1016/j.neo.2023.100923. Epub 2023 Aug 19.
8
Scientific connotation of the compatibility of traditional Chinese medicine from the perspective of the intestinal flora.
Front Pharmacol. 2023 Jul 19;14:1152858. doi: 10.3389/fphar.2023.1152858. eCollection 2023.
9
Gut microbiota: Role and Association with Tumorigenesis in Different Malignancies.
Mol Biol Rep. 2022 Aug;49(8):8087-8107. doi: 10.1007/s11033-022-07357-6. Epub 2022 May 11.

本文引用的文献

1
Innate immunity and intestinal microbiota in the development of Type 1 diabetes.
Nature. 2008 Oct 23;455(7216):1109-13. doi: 10.1038/nature07336. Epub 2008 Sep 21.
2
Human colonic microbiota associated with diet, obesity and weight loss.
Int J Obes (Lond). 2008 Nov;32(11):1720-4. doi: 10.1038/ijo.2008.155. Epub 2008 Sep 9.
3
Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome.
Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13580-5. doi: 10.1073/pnas.0804437105. Epub 2008 Aug 29.
4
Predominant role of host genetics in controlling the composition of gut microbiota.
PLoS One. 2008 Aug 26;3(8):e3064. doi: 10.1371/journal.pone.0003064.
6
Comparative analysis of human gut microbiota by barcoded pyrosequencing.
PLoS One. 2008 Jul 30;3(7):e2836. doi: 10.1371/journal.pone.0002836.
7
Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases.
Cell Host Microbe. 2008 Jun 12;3(6):417-27. doi: 10.1016/j.chom.2008.05.001.
8
Modulation of the maturing gut barrier and microbiota: a novel target in allergic disease.
Curr Pharm Des. 2008;14(14):1368-75. doi: 10.2174/138161208784480207.
10
Metagenomic analysis of human diarrhea: viral detection and discovery.
PLoS Pathog. 2008 Feb 29;4(2):e1000011. doi: 10.1371/journal.ppat.1000011.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验